Yeeran

Application of Mouse and Rat Ultrasound in Tumor Research – Technical Pain Points in Tumor Research and the Value of Multimodal Ultrasound Applications

Building on the previous five installments, we have systematically established a complete research system for cardiovascular ultrasound in mice and rats, comprehensively covering the fundamental principles of ultrasound, anatomical features of the animal heart, core measurement indicators, standardized practical protocols for various cardiovascular disease models, and full-process experimental quality control standards. This provides researchers with a standardized, replicable technical reference system for cardiovascular animal experiments.

In fact, high-frequency small-animal ultrasound is not limited to cardiovascular research. Leveraging its unique technical advantages—non-invasive in vivo imaging, high soft-tissue resolution, dynamic longitudinal follow-up, and multi-dimensional quantitative analysis—it also holds irreplaceable value in basic tumor research, anti-tumor efficacy evaluation, and exploration of tumor microenvironment mechanisms.

In current in vivo tumor research, traditional detection techniques still have many inherent shortcomings, including poor data reproducibility, single-dimensional observation, inability to capture early pathological functional changes, and high invasiveness. These pain points severely limit experimental depth and research innovation.

To address this, this installment focuses on the systematic application of small-animal ultrasound in the field of tumor research. This article systematically reviews the limitations of traditional in vivo tumor detection techniques, with emphasis on the scientific value and practical application scenarios of multimodal ultrasound technologies—including B‑mode ultrasound, color Doppler, contrast‑enhanced ultrasound, ultrasound cavitation, shear‑wave elastography, and super‑resolution microvascular imaging—in tumor models. It aims to provide systematic, standardized technical strategies for in vivo tumor experimental design, multi‑dimensional data mining, and high‑level research outputs.

---

I. Mainstream In Vivo Tumor Research Technologies and Core Scientific Pain Points

Currently, the main evaluation methods for in vivo tumor research in mice and rats include endpoint anatomical examination, in vivo optical imaging, Micro‑CT, Micro‑MRI, and invasive biopsy. Although these techniques are widely used for tumor model validation and efficacy evaluation, each has unavoidable experimental limitations due to its underlying principles, making it difficult to meet the current demands for refined, dynamic, and multi‑dimensional tumor research.

1.1 Endpoint Anatomical Sampling (Tumor Weighing, Histopathological Sections)

Anatomical weighing and histopathological examination are the classic gold‑standard methods in tumor research. By euthanizing animals and excising tumor tissues, researchers obtain tumor weight, volume statistics, as well as postoperative pathological morphology and protein expression analysis.

Core Technical Pain Points:

This method is a destructive endpoint assay, providing only static data at a single time point. It cannot enable long‑term dynamic follow‑up of the same experimental animal, nor can it capture the continuous dynamic evolution of tumor proliferation and regression. Inter‑individual differences in tumor growth cannot be eliminated through self‑controlled comparisons, requiring larger sample sizes to compensate for statistical errors, which significantly increases experimental costs and animal loss. Moreover, endpoint sampling cannot observe in vivo tumor necrosis, cystic changes, hemorrhage, or microvascular neovascularization, making it difficult to truly reflect the biological behavior of tumors in living organisms, nor can it dynamically assess tumor infiltration and invasion into surrounding tissues.

1.2 In Vivo Optical Imaging (Fluorescence / Bioluminescence Imaging, BLI)

In vivo optical imaging, owing to its ease of operation and high throughput, is commonly used for tumor cell tracing and qualitative screening of distant metastases, and is currently a widely used technique for in vivo tumor screening.

Core Technical Pain Points:

This technique has relatively low spatial resolution and can only provide qualitative analysis of signal intensity, without accurately quantifying the true volume of solid tumors—leading to significant quantitative errors. Bioluminescent/fluorescent signals are easily attenuated by absorption in skin, muscle, and deep tissues; signals from tumors in deep organs are markedly attenuated and poorly localized, making it impossible to distinguish lesion depth or signal origin. Additionally, optical imaging cannot resolve internal structural differences within tumors, cannot identify pathological changes such as necrosis, cystic degeneration, or hemorrhage, and cannot assess tumor microvascular perfusion or hemodynamic characteristics. Furthermore, most of these techniques rely on fluorescent/luciferase labeling of tumor cells and are not applicable to unlabeled models such as primary tumors or patient‑derived xenografts (PDX), resulting in clear limitations in applicable scenarios.

1.3 Micro‑Computed Tomography (Micro‑CT)

Micro‑CT relies on tissue‑density differences for imaging and is mostly used for screening and evaluating structural lesions such as pulmonary tumors and bone metastases.

Core Technical Pain Points:

Micro‑CT has extremely poor soft‑tissue contrast; the boundaries between soft‑tissue tumors and surrounding normal tissues are indistinct, making it difficult to accurately delineate tumor contours or measure tumor volume. The equipment involves ionizing radiation, and frequent repeated scanning can cause physical damage to the animals, potentially interfering with tumor proliferation and biological behavior, rendering it unsuitable for long‑term dynamic follow‑up. Moreover, this technique only visualizes macroscopic structural morphology and cannot assess microcirculatory perfusion, angiogenesis, or functional changes in tissues. Additionally, the equipment is expensive to purchase and maintain, making it challenging for routine research groups to adopt.

1.4 Small‑Animal Magnetic Resonance Imaging (Micro‑MRI)

Micro‑MRI offers excellent soft‑tissue resolution and can clearly display tumor structures in deep organs, making it one of the high‑precision imaging modalities.

Core Technical Pain Points:

Micro‑MRI requires a long scanning time per sample, resulting in low throughput, and is not suitable for large‑scale drug efficacy screening experiments. The equipment is extremely costly, with stringent requirements for site and maintenance, posing a high barrier for ordinary research teams. Furthermore, parameter adjustment is complex and the workflow cumbersome, making it difficult to achieve short‑interval, multi‑point dynamic time‑series monitoring. Conventional sequences also cannot accurately assess hemodynamic changes in the tumor microcirculation, limiting their utility for tumor microenvironment and early pharmacodynamic studies.

1.5 Invasive Biopsy

Needle biopsy can obtain living tumor tissue for subsequent molecular biology and immunohistochemical analyses, enabling the study of micro‑mechanisms of tumors.

Core Technical Pain Points:

Biopsy is an invasive procedure that can easily cause tumor rupture, local hemorrhage, inflammatory infiltration, and even ectopic implantation and metastasis, thereby interfering with experimental results. Moreover, biopsy only retrieves a small amount of local tissue, which cannot reflect the overall heterogeneity of the tumor, and repeated sampling is not feasible, making dynamic monitoring difficult.

In summary, traditional detection techniques generally suffer from single observational dimensions, high invasiveness, inability to perform dynamic quantitative assessment, low early sensitivity, and high barriers to use. They cannot simultaneously integrate multi‑dimensional evaluations of tumor morphology, microcirculatory function, and tissue mechanical properties. In contrast, high‑frequency small‑animal ultrasound equipped with multimodal imaging capabilities can perfectly compensate for the shortcomings of traditional technical systems and has become a core tool for refined tumor research.

---

II. Core Application System of Multimodal Small‑Animal Ultrasound in Tumor Research

High‑frequency small‑animal ultrasound, utilizing ultra‑high‑frequency probes of 10–40 MHz, offers excellent soft‑tissue resolution. It requires no cell labeling, involves no ionizing radiation, and enables repeated non‑invasive testing. Beyond basic B‑mode imaging and Doppler flow imaging, four advanced modalities—contrast‑enhanced ultrasound, ultrasound cavitation, shear‑wave elastography, and super‑resolution ultrasound imaging—can comprehensively analyze tumor growth characteristics, invasion mechanisms, and drug response patterns from five dimensions: macroscopic morphology, microcirculatory perfusion, physical targeted intervention, tissue mechanical microenvironment, and fine microvascular structure. Together, they cover the full spectrum of basic tumor research, mechanistic exploration, and efficacy evaluation.

2.1 Basic B‑Mode Ultrasound + Color Doppler Flow Imaging (CDFI)

As the foundational modalities for tumor ultrasound research, B‑mode ultrasound can clearly display the morphology and structure of various solid tumors—including subcutaneous xenografts, orthotopic liver tumors, orthotopic breast tumors, and pancreatic tumors—and accurately delineate tumor boundaries. By measuring the long diameter, short diameter, and thickness, combined with the ellipsoid volume formula, it enables dynamic quantitative measurement of tumor volume and the continuous plotting of tumor growth curves. This technique can detect early micro‑lesions invisible to the naked eye and, through intra‑animal before‑and‑after comparisons, effectively eliminates individual differences, reduces required sample sizes, and enhances data reliability.

Color Doppler flow imaging can visually display the distribution and vascularity of large vessels within and around the tumor, providing a preliminary assessment of the level of tumor angiogenesis. At the same time, it can clearly visualize pathological features such as tumor capsule integrity, surrounding tissue infiltration, and regional lymph node enlargement, providing morphological evidence for preliminary evaluation of tumor proliferation and invasive characteristics.

2.2 Contrast‑Enhanced Ultrasound (CEUS): Precise Quantification of Tumor Microcirculatory Perfusion

Contrast‑enhanced ultrasound (CEUS) is a core advanced technique for evaluating tumor microcirculation and assessing anti‑tumor efficacy at an early stage. By intravenously injecting micron‑sized ultrasound microbubble contrast agents, CEUS enables specific imaging of the tumor microvascular network, overcoming the limitation of conventional Doppler, which only visualizes larger vessels.

Its core scientific value is primarily reflected in three aspects:

First, early efficacy prediction. By obtaining quantitative perfusion parameters such as peak intensity (PI), time to peak (TTP), and area under the curve (AUC), CEUS can accurately reflect tumor microvascular density and blood perfusion levels. For anti‑angiogenic targeted drugs, it can detect microcirculatory perfusion inhibition at an early stage, even before the tumor volume shows significant reduction, greatly enhancing experimental detection sensitivity.

Figure 3: Contrast‑Enhanced Ultrasound (CEUS) Data Analysis.

 

Second, in vivo differentiation between viable tumor and necrotic areas. Viable tumor tissue is richly vascularized, showing rapid contrast agent filling and homogeneous enhancement, whereas necrotic and cystic areas lack microbubble perfusion and appear as non‑enhancing regions. This allows in vivo quantification of the necrotic proportion of the tumor and precise evaluation of drug‑induced tumor regression.

Third, lesion characterization and metastasis assessment. Malignant tumors typically exhibit a characteristic “fast‑in, fast‑out” pattern with heterogeneous hyperenhancement, which effectively distinguishes benign from malignant lesions and from hyperplastic lymph nodes. At the same time, it can precisely screen perfusion characteristics of micro‑metastases in deep organs such as the abdominal cavity and liver, providing functional data for studying tumor metastasis mechanisms.

---

2.3 Ultrasound Cavitation: Targeted Tumor Damage and Synergistic Therapy Research

Ultrasound cavitation is a physical‑biological effect mediated by high‑frequency ultrasound combined with microbubbles. It refers to the dynamic process in which ultrasound waves induce microbubble oscillation, contraction, expansion, and even transient collapse within tissues, generating transient high temperatures, high pressure, micro‑jets, and mechanical shear forces at the tumor site. This represents a cutting‑edge research direction for novel physical cancer therapies, drug delivery enhancement, and radio‑/chemosensitization. Unlike conventional imaging modalities, ultrasound cavitation focuses on tumor intervention and therapeutic potentiation, enabling integrated “imaging‑guided monitoring + targeted intervention” research.

Its core scientific value is primarily reflected in three aspects:

First, targeted disruption of the tumor microvascular barrier. Stable cavitation can moderately damage the endothelial structure of tumor neovasculature, disrupting aberrant vascular integrity, inhibiting tumor blood supply, and blocking nutrient delivery, thereby suppressing tumor proliferation, invasion, and metastasis. This provides a novel physical intervention target for anti‑angiogenic therapy.

Second, enhanced targeted drug delivery to tumors. Ultrasound cavitation can transiently and reversibly open the endothelial gaps in tumor blood vessels and increase cell membrane permeability, effectively addressing the problems of poor drug penetration and low accumulation in tumor tissues, reversing drug resistance, and significantly enhancing the tumor‑targeted accumulation and therapeutic efficacy of chemotherapeutic agents and nano‑drug delivery systems.

Third, precisely induced local tumor damage and radio‑/chemosensitization. The mechanical damage and oxidative stress effects generated by transient cavitation can directly induce apoptosis and necrosis in some tumor cells. At the same time, it can improve the hypoxic tumor microenvironment, effectively sensitizing radiotherapy and chemotherapy. This provides critical technical support for research on combination therapy mechanisms and the development of novel physical anti‑tumor strategies.

Compared with traditional therapeutic approaches, ultrasound cavitation offers advantages including non‑invasive targeting, locally precise action, minimal damage to normal tissues, and real‑time ultrasound monitoring of the intervention process. It is widely applied in cutting‑edge topics such as tumor drug potentiation, vascular‑targeted intervention, and combination therapy mechanisms.

---

2.4 Shear‑Wave Elastography (SWE): Quantitative Characterization of the Tumor Mechanical Microenvironment

Shear‑wave elastography (SWE) is a dedicated technique for non‑invasively assessing tumor tissue stiffness and characterizing the tumor mechanical microenvironment. By measuring the propagation speed of shear waves within tissues, it quantitatively calculates the tissue elastic modulus (in kPa), enabling objective quantification of tumor stiffness and completely eliminating the subjective bias of traditional palpation.

Tumor proliferation, invasion, and metastatic capacity are highly correlated with tissue mechanical properties. Malignant tumors, due to abnormal cell proliferation and matrix fibrotic remodeling, exhibit significantly higher tissue stiffness than normal tissues and benign lesions. SWE can precisely distinguish the tumor boundary from surrounding normal tissue and quantitatively monitor the dynamic evolution of matrix fibrosis during tumor progression. At the same time, it can dynamically assess stiffness changes induced by tumor necrosis and fibrotic remodeling following drug intervention, elucidating the mechanisms of anti‑tumor drugs from the perspective of the mechanical microenvironment. This represents an important innovative entry point for tumor mechanism research.

---

2.5 Ultrasound Super‑Resolution Imaging (USR): Visualization of Fine Microvascular Structures

Ultrasound super‑resolution (USR) imaging breaks through the diffraction limit of conventional ultrasound, elevating imaging resolution to the micron level and enabling ultra‑high‑precision visualization of the tumor microvascular network. It is currently a core innovative technique for high‑level research on the tumor microenvironment and angiogenesis mechanisms.

Conventional ultrasound and standard contrast imaging can only visualize macroscopic tumor blood perfusion and cannot resolve the fine structure of microvessels. In contrast, super‑resolution imaging can clearly delineate microvessel diameter, tortuosity, branch density, and spatial distribution patterns within tumors, and precisely quantify high‑level indices such as microvessel density, inter‑vessel distance, and fractal dimension. It can accurately capture subtle pathological changes such as early microvascular remodeling and angiogenesis at the invasive front, providing a new data dimension for in‑depth research on tumor angiogenesis, invasion, and metastasis.

---

2.6 Expanded Research Applications of Multimodal Fusion

Multimodal small‑animal ultrasound enables synergistic complementation of multiple techniques to construct a comprehensive tumor evaluation system. It can non‑invasively screen for micro‑metastases in deep organs throughout the body and lymph node infiltration; it can also guide orthotopic tumor inoculation, intratumoral precision drug administration, and minimally invasive biopsy procedures under real‑time ultrasound guidance, greatly improving model establishment success rates and experimental accuracy. At the same time, it perfectly complements in vivo optical imaging and endpoint pathological examination, establishing a full‑chain research evaluation system that integrates in vivo dynamic morphological observation, quantitative microcirculatory function, physical cavitation intervention, mechanical microenvironment characterization, fine microvascular analysis, and endpoint pathological validation.

---

III. Core Research Advantages of Multimodal Small‑Animal Ultrasound

Compared with traditional tumor detection techniques, multimodal small‑animal ultrasound is well‑suited to current refined tumor research needs and offers multiple irreplaceable core advantages:

01 Completely non‑invasive and radiation‑free, supporting long‑term high‑frequency follow‑up: With no ionizing radiation and no physical trauma, it does not interfere with tumor biological behavior, allows continuous monitoring of the same animal at multiple time points, avoids inter‑individual variability, and reduces the number of experimental animals required.

02 Comprehensive detection dimensions, integrating structure and function: It simultaneously enables multi‑dimensional quantitative assessment of tumor morphology, size, boundary infiltration, blood perfusion, microvascular structure, and tissue stiffness, capturing early functional pathological changes that traditional techniques cannot detect.

03 No cell labeling required, broad model applicability: Independent of fluorescent or luciferase gene labeling, it can be widely applied to various models including CDX cell‑line xenografts, PDX primary tumors, spontaneous tumors, and orthotopic tumors, with no limitations in applicable scenarios.

04 High efficiency, high throughput, and controllable cost: Rapid per‑sample detection makes it suitable for large‑scale anti‑tumor drug screening experiments. Equipment maintenance and per‑test costs are far lower than those of Micro‑CT and Micro‑MRI, making it suitable for routine use in research groups.

05 Real‑time dynamic imaging, supporting minimally invasive interventional guidance: With clear real‑time imaging, it can precisely guide various minimally invasive procedures, overcoming the problems of high trauma and low accuracy associated with traditional blind procedures.

---

Review

Reviewing the previous five installments on cardiovascular ultrasound, we completed the comprehensive establishment of the theoretical foundations of small‑animal ultrasound and practical protocols for cardiovascular models. This installment extends into the field of tumor research, systematically confirming that multimodal small‑animal ultrasound is a core tool for breaking through the pain points of traditional tumor detection techniques and enhancing the depth of tumor research.

Given the current trend toward refined and multi‑dimensional tumor research, relying solely on traditional indicators such as tumor volume and endpoint pathology is no longer sufficient to meet the innovation requirements of high‑level publications. Multimodal small‑animal ultrasound technology—integrating structural morphology, microcirculatory perfusion, fine microvascular structure, tissue mechanical properties, and physical cavitation intervention—can deeply explore dynamic in vivo tumor characteristics and novel intervention mechanisms, providing strong technical support for tumor mechanism investigation, novel drug efficacy evaluation, physical combination therapy, and the discovery of innovative research directions.

In the future, we will continue to deepen our efforts in the field of small‑animal ultrasound research, regularly providing high‑quality ultrasound content across tumor, cardiovascular, and other fields, and continuously refining the small‑animal ultrasound research system. We aim to help researchers standardize experimental procedures and produce high‑quality scientific outputs. We welcome your continued attention and ongoing learning!